Literature DB >> 15105101

Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin.

Robert Bucki1, Jennifer J Pastore, Paramjeet Randhawa, Rolands Vegners, Daniel J Weiner, Paul A Janmey.   

Abstract

The growing number of antibiotic-resistant bacteria necessitates the search for new antimicrobial agents and the principles by which they work. We report that cell membrane-permeant rhodamine B (RhB)-conjugated peptides based on the phosphatidylinositol-4,5-bisphosphate binding site of gelsolin can kill the gram-negative organisms Escherichia coli and Pseudomonas aeruginosa and the gram-positive organism Streptococcus pneumoniae. RhB linkage to the QRLFQVKGRR sequence in gelsolin was essential for the antibacterial function, since the unconjugated peptide had no effect on the bacteria tested. Because RhB-QRLFQVKGRR (also termed PBP10), its scrambled sequence (RhB-FRVKLKQGQR), and PBP10 synthesized from D-isomer amino acids show similar antibacterial properties, the physical and chemical properties of these derivatives appear to be more important than specific peptide folding for their antibacterial functions. The similar activities of PBP10 and all-D-amino-acid PBP10 also indicate that a specific interaction between RhB derivatives and bacterial proteins is unlikely to be involved in the bacterial killing function of PBP10. By using a phospholipid monolayer system, we found a positive correlation between the antibacterial function of PBP10, as well as some naturally occurring antibacterial peptides, and the intrinsic surface pressure activity at the hydrophobic-hydrophilic interface. Surprisingly, we observed little or no dependence of the insertion of these peptides into lipid monolayers on the phospholipid composition. These studies show that an effective antimicrobial agent can be produced from a peptide sequence with specificity to a phospholipid not found in bacteria, and comparisons with other antimicrobial agents suggest that the surface activities of these peptides are more important than specific binding to bacterial proteins or lipids for their antimicrobial functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15105101      PMCID: PMC400557          DOI: 10.1128/AAC.48.5.1526-1533.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

Review 1.  Properties of cytotoxic peptide-formed ion channels.

Authors:  J I Kourie; A A Shorthouse
Journal:  Am J Physiol Cell Physiol       Date:  2000-06       Impact factor: 4.249

2.  Design and synthesis of novel antimicrobial pseudopeptides with selective membrane-perturbation activity.

Authors:  K H Lee; J E Oh
Journal:  Bioorg Med Chem       Date:  2000-04       Impact factor: 3.641

Review 3.  Structure and biology of cathelicidins.

Authors:  M Zanetti; R Gennaro; M Scocchi; B Skerlavaj
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

4.  CRAMP analogues having potent antibiotic activity against bacterial, fungal, and tumor cells without hemolytic activity.

Authors:  S Y Shin; S W Kang; D G Lee; S H Eom; W K Song; J I Kim
Journal:  Biochem Biophys Res Commun       Date:  2000-09-07       Impact factor: 3.575

Review 5.  Lipid monolayers: why use half a membrane to characterize protein-membrane interactions?

Authors:  H Brockman
Journal:  Curr Opin Struct Biol       Date:  1999-08       Impact factor: 6.809

6.  Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures.

Authors:  D Oh; S Y Shin; S Lee; J H Kang; S D Kim; P D Ryu; K S Hahm; Y Kim
Journal:  Biochemistry       Date:  2000-10-03       Impact factor: 3.162

7.  Diabetes affects phospholipid content in the nuclei of the rat liver.

Authors:  M Zendzian-Piotrowska; R Bucki; M Górska; J Górski
Journal:  Horm Metab Res       Date:  2000-10       Impact factor: 2.936

8.  Bactericidal activity of mammalian cathelicidin-derived peptides.

Authors:  S M Travis; N N Anderson; W R Forsyth; C Espiritu; B D Conway; E P Greenberg; P B McCray; R I Lehrer; M J Welsh; B F Tack
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  Bile acid secretion and direct targeting of mdr1-green fluorescent protein from Golgi to the canalicular membrane in polarized WIF-B cells.

Authors:  Y Sai; A T Nies; I M Arias
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

10.  LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

Authors:  Q Chen; A P Schmidt; G M Anderson; J M Wang; J Wooters; J J Oppenheim; O Chertov
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  35 in total

1.  Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability.

Authors:  Fitzroy J Byfield; Qi Wen; Katarzyna Leszczynska; Alina Kulakowska; Zbigniew Namiot; Paul A Janmey; Robert Bucki
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-13       Impact factor: 4.249

2.  Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.

Authors:  Urszula Wnorowska; Katarzyna Niemirowicz; Melissa Myint; Scott L Diamond; Marta Wróblewska; Paul B Savage; Paul A Janmey; Robert Bucki
Journal:  Antimicrob Agents Chemother       Date:  2015-04-13       Impact factor: 5.191

3.  Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes.

Authors:  Robert Bucki; Paul A Janmey
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 4.  Peptide antimicrobial agents.

Authors:  Håvard Jenssen; Pamela Hamill; Robert E W Hancock
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

5.  Process of inducing pores in membranes by melittin.

Authors:  Ming-Tao Lee; Tzu-Lin Sun; Wei-Chin Hung; Huey W Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

6.  Fluorescent temporin B derivative and its binding to liposomes.

Authors:  Rohit Sood; Yegor Domanov; Paavo K J Kinnunen
Journal:  J Fluoresc       Date:  2007-02-06       Impact factor: 2.217

Review 7.  Comparison between the behavior of different hydrophobic peptides allowing membrane anchoring of proteins.

Authors:  Mustapha Lhor; Sarah C Bernier; Habib Horchani; Sylvain Bussières; Line Cantin; Bernard Desbat; Christian Salesse
Journal:  Adv Colloid Interface Sci       Date:  2014-01-28       Impact factor: 12.984

8.  Mode of Action of Antimicrobial Peptides on E. coli Spheroplasts.

Authors:  Yen Sun; Tzu-Lin Sun; Huey W Huang
Journal:  Biophys J       Date:  2016-07-12       Impact factor: 4.033

9.  Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13.

Authors:  Robert Bucki; Dorota B Namiot; Zbigniew Namiot; Paul B Savage; Paul A Janmey
Journal:  J Antimicrob Chemother       Date:  2008-05-01       Impact factor: 5.790

10.  Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice.

Authors:  Katarzyna Leszczyńska; Andrzej Namiot; David E Fein; Qi Wen; Zbigniew Namiot; Paul B Savage; Scott Diamond; Paul A Janmey; Robert Bucki
Journal:  BMC Microbiol       Date:  2009-09-03       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.